Immediate Impact
7 standout
Citing Papers
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Combined photothermal and sonodynamic therapy using a 2D black phosphorus nanosheets loaded coating for efficient bacterial inhibition and bone-implant integration
2023 Standout
Works of C. Shen being referenced
Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| C. Shen | 20 | 19 | 10 | 21 | 19 | 9 | 50 | |
| Iain McPherson | 18 | 15 | 10 | 18 | 9 | 8 | 52 | |
| Henry W. Edmonds | 52 | 13 | 2 | 51 | 37 | 7 | 164 | |
| Scott Regan | 11 | 11 | 8 | 10 | 9 | 63 | ||
| Megan Jenkins | 33 | 4 | 6 | 10 | 4 | 11 | 48 | |
| James Yang | 22 | 15 | 29 | 20 | 9 | 165 | ||
| Fatemeh Kafi | 9 | 8 | 16 | 18 | 10 | 38 | ||
| Laura Fortuna | 30 | 13 | 5 | 23 | 4 | 12 | 47 | |
| Adrian Brodison | 18 | 5 | 13 | 33 | 8 | 58 | ||
| Yifan Hong | 15 | 5 | 23 | 9 | 13 | 48 | ||
| Paul S. Lavik | 37 | 17 | 6 | 45 | 6 | 15 | 168 |
All Works
Login with ORCID to disown or claim papers
Loading papers...